Fig. 5.
SGLT2i treatment efficacy in people both with and without established CVD or HF [97]. a Meta-analysis of MACE outcomes stratified by presence of established CVD. b Meta-analysis of HHF and CV death stratified by presence of established CVD. c Meta-analysis of HHF and CV death stratified by history of HF.
Adapted with permission from Zelniker et al. [97]